Top Biotechnology & Medical Research stocks in North America
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
ARCTArcturus Therapeutics Holdings | $640.71m | n/a | n/a |
PHATPhathom Pharmaceuticals | $640.67m | n/a | n/a |
PRMEPrime Medicine | $636.76m | n/a | n/a |
IGMSIGM Biosciences | $633.91m | n/a | n/a |
AVBPArriVent Biopharma | $628.68m | n/a | n/a |
TRDAEntrada Therapeutics | $627.77m | 27.07 | n/a |
DNAGinkgo Bioworks Holdings | $623.95m | n/a | n/a |
CRBPCorbus Pharmaceuticals Holdings | $619.83m | n/a | n/a |
RGNXRegenxbio | $619.64m | n/a | n/a |
ATXSAstria Therapeutics | $615.03m | n/a | n/a |
CELCCelcuity | $606.55m | n/a | n/a |
PROKProkidney | $597.38m | n/a | n/a |
ADPTAdaptive Biotechnologies | $595.37m | n/a | n/a |
LRMRLarimar Therapeutics | $594.63m | n/a | n/a |
ALLOAllogene Therapeutics | $589.73m | n/a | n/a |
APLTApplied Therapeutics | $587.33m | n/a | n/a |
ANNXAnnexon | $582.61m | n/a | n/a |
VERVVerve Therapeutics | $578.52m | n/a | n/a |
GHRSGH Research | $574.91m | n/a | n/a |
MNMDMind Medicine (MindMed) | $569.95m | n/a | n/a |